Lactoferrin protects against chemical-induced rat liver fibrosis by inhibiting stellate cell activation

Journal of Dairy Science

Volumn 97, Issue 6, 2014, Pages 3281-3291

  Tung, Yu Tang ^a   Tang, Ting Yu ^a   Chen, Hsiao Ling ^b   Yang, Shang Hsun ^c   Chong, Kowit Yu ^d   Cheng, Winston T K ^e   Chen, Chuan Mu ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b DA YEH UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Dimethylnitrosamine; Hepatic stellate cells; Lactoferrin; Liver fibrosis

Indexed keywords

DIMETHYLNITROSAMINE; HYDROXYPROLINE; LACTOFERRIN; MESSENGER RNA;

ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; ECHOGRAPHY; GENETICS; LIVER; LIVER CIRRHOSIS; MALE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; DIMETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; HYDROXYPROLINE; LACTOFERRIN; LIVER; LIVER CIRRHOSIS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 84901006297     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2013-7505     Document Type: Article

References (43)

1. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005, 115:209-218.
2. Britton J.R., Koldovsky O. Gastric luminal digestion of lactoferrin and transferrin by preterm infants. Early Hum. Dev. 1989, 19:127-135.
3. Chen J.Y., Chen H.L., Cheng J.C., Lin H.J., Tung Y.T., Lin C.F., Chen C.M. A Chinese herbal medicine, Gexia-Zhuyu Tang (GZT), prevents dimethylnitrosamine-induced liver fibrosis through inhibition of hepatic stellate cells proliferation. J. Ethnopharmacol. 2012, 142:811-818. a.
4. Chen J.Y., Chen H.L., Wu S.H., Tsai T.C., Lin M.F., Yen C.C., Hsu W.H., Chen W., Chen C.M. Application of high-frequency ultrasound for the detection of surgical anatomy in the rodent abdomen. Vet. J. 2012, 191:246-252. b.
5. Chen W., Chen J.Y., Chen H.L., Tung Y.T., Kuo C.W., Mao F.C., Chuang C.H., Chong K.Y., Chen C.M. High-frequency ultrasound imaging to evaluate liver fibrosis progression in rats and Yi Guan Jian herbal therapeutic effects. Evid. Based Complement. Alternat. Med. 2013.
6. Chodaczek G., Saavedra-Molina A., Bacsi A., Kruzel M.L., Sur S., Boldogh I. Iron-mediated dismutation of superoxide anion augments antigen-induced allergic inflammation: Effect of lactoferrin. Postepy Hig. Med. Dosw. (Online) 2007, 61:268-276.
7. Cumberbatch M., Dearman R.J., Uribe-Luna S., Headon D.R., Ward P.P., Conneely O.M., Kimber I. Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology 2000, 100:21-28.
8. de Lima V.M., Oliveira C.P., Alves V.A., Chammas M.C., Oliveira E.P., Stefano J.T., de Mello E.S., Cerri G.G., Carrilho F.J., Caldwell S.H. A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J. Hepatol. 2008, 49:1055-1061.
9. de Mejia E.G., Dia V.P. The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells. Cancer Metastasis Rev. 2010, 29:511-528.
10. Elsharkawy A.M., Oakley F., Lin F., Packham G., Mann D.A., Mann J. The NF-κB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J. Hepatol. 2010, 53:519-527.
11. Elsharkawy A.M., Oakley F., Mann D.A. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005, 10:927-939.
12. Friedman S.L. Liver fibrosis-From bench to bedside. J. Hepatol. 2003, 38:S38-S53.
13. Friedman S.L. Hepatic stellate cells-Protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88:125-172.
14. George J., Chandrakasan G. Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine. Clin. Biochem. 2000, 33:563-570.
15. Gressner O.A., Weiskirchen R., Gressner A.M. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J. Cell. Mol. Med. 2007, 11:1031-1051.
16. Guengerich F.P., Kim D.H., Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 1991, 4:168-179.
17. Guimond A., Teletin M., Garo E., D'Sa A., Selloum M., Champy M.F., Vonesch J.L., Monassier L. Quantitative ultrasonic tissue characterization as a new tool for continuous monitoring of chronic liver remodelling in mice. Liver Int. 2007, 27:854-864.
18. Hayashida K., Kaneko T., Takeuchi T., Shimizu H., Ando K., Harada E. Oral administration of lactoferrin inhibits inflammation and noiception in rat adjuvant-inducedarthritis. J. Vet. Med. Sci. 2004, 66:149-154.
19. Ishikado A., Imakana H., Takeuchi T., Harada E., Makino T. Liposomalization of lactoferrin enhanced its anti-inflammatory effects via oral administration. Biol. Pharm. Bull. 2005, 28:1717-1721.
20. Jamall I.S., Finelli V.N., Que Hee S.S. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal. Biochem. 1981, 112:70-75.
21. Jézéquel A.M., Mancini R., Rinaldesi M.L., Macarri G., Venturini C., Orlandi F. A morphological study of the early stage of hepatic fibrosis induced by low dose of DMN in the rats. J. Hepatol. 1987, 5:174-181.
22. Kisseleva T., Brenner D.A. Hepatic stellate cells and the reversal of fibrosis. J. Gastroenterol. Hepatol. 2006, 21:S84-S87.
23. Lee M.F., Tsai M.L., Sun P.P., Chien L.L., Cheng A.C., Ma N.J., Ho C.T., Pan M.H. Phyto-power dietary supplement potently inhibits dimethylnitrosamine-induced liver fibrosis in rats. Food Funct. 2013, 4:470-475.
24. Levay P.F., Viljoen M. Lactoferrin: A general review. Haematologica 1995, 80:252-267.
25. Liu H.C., Pai S.Y., Cheng W.T., Chen H.L., Tsai T.C., Yang S.H., Chen C.M. Ingestion of milk containing the Dp2 peptide, a dust mite allergen, protects mice from allergic airway inflammation and hyper-responsiveness. Allergy Asthma Clin. Immunol. 2013, 9:21.
26. Matsuhashi T., Yamada N., Shinzawa H., Takahashi T. An evaluation of hepatic ultrasound speed in injury models in rats: Correlation with tissue constituents. J. Ultrasound Med. 1996, 15:563-570.
27. Mazurier J., Legrand D., Hu W.L., Montreuil J., Spik G. Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. Eur. J. Biochem. 1989, 179:481-487.
28. Nakamuta M., Ohta S., Tada S., Tsuruta S., Sugimoto R., Kotoh K., Kato M., Nakashima Y., Enjoji M., Nawata H. Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Int. J. Mol. Med. 2001, 8:553-560.
29. Ochoa T.J., Chea-Woo E., Campos M., Pecho I., Prada A., McMahon R.J., Cleary T.G. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin. Infect. Dis. 2008, 46:1881-1883.
30. Parola M., Robino G. Oxidative stress-related molecules and liver fibrosis. J. Hepatol. 2001, 35:297-306.
31. Reeves H.L., Burt A.D., Wood S., Day C.P. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J. Hepatol. 1996, 25:677-683.
32. Shen C.J., Lin C.C., Shen P.C., Cheng W.T., Chen H.L., Chang T.C., Liu S.S., Chen C.M. Imprinted genes and satellite loci are differentially methylated in bovine somatic cell nuclear transfer clones. Cell. Reprogram. 2013, 15:413-424.
33. Spik G., Brunet B., Mazurier-Dehaine C., Fontaine G., Montreuil J. Characterization and properties of the human and bovine lactotransferrins extracted from the faeces of newborn infants. Acta Paediatr. Scand. 1982, 71:979-985.
34. Teufelhofer O., Parzefall W., Kainzbauer E., Ferk F., Freiler C., Knasmüller S., Elbling L., Thurman R., Schulte-Hermann R. Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: Studies on NADPH oxidase knockout mice. Carcinogenesis 2005, 26:319-329.
35. Togawa J., Nagase H., Tanaka K., Inamori M., Umezawa T., Nakajima A., Naito M., Sato S., Saito T., Sekihara H. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283:G187-G195.
36. Troost F.J., Steijns J., Saris W.H., Brummer R.J. Gastric digestion of bovine lactoferrin in vivo in adults. J. Nutr. 2001, 131:2101-2104.
37. Tung Y.T., Chen H.L., Lai C.W., Shen C.J., Lai Y.W., Chen C.M. Curcumin reduces pulmonary tumorigenesis in vascular endothelial growth factor (VEGF)-overexpressing transgenic mice. Mol. Nutr. Food Res. 2011, 55:1036-1043.
38. Tung Y.T., Chen H.L., Tsai H.C., Yang S.H., Chang Y.C., Chen C.M. Therapeutic potential of andrographolide isolated from the leaves of Andrographis paniculata Nees for treating lung adenocarcinomas. Evid. Based Complement. Alternat. Med. 2013, 2013:305898. a.
39. Tung Y.T., Chen H.L., Yen C.C., Lee P.Y., Tsai H.C., Lin M.F., Chen C.M. Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor. J. Dairy Sci. 2013, 96:2095-2106. b.
40. Van Snick J.L., Masson P.L. The binding of human lactoferrin to mouse peritoneal cells. J. Exp. Med. 1976, 144:1568-1580.
41. Wen S.T., Chen W., Chen H.L., Lai C.W., Yen C.C., Lee K.H., Wu S.C., Chen C.M. Amniotic fluid stem cells from EGFP transgenic mice attenuate hyperoxia-induced acute lung injury. PLoS ONE 2013, 8:e75383.
42. Yamauchi K., Wakabayashi H., Hashimoto S., Teraguchi S., Hayasawa H., Tomita M. Effect of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv. Exp. Med. Biol. 1998, 443:261-265.
43. Yan G., Duan Y., Ruan L., Yang Y., Cao T. Experimental study on the relation between the noninvasive ultrasonography quantitative scoring system and the degree of the hepatic fibrosis. Hepatogastroenterology 2007, 54:1908-1914.